A nurse is caring for a patient with Systemic Lupus Erythematosus (SLE). The nurse would ask the validity of this sign or symptom listed in the patient's chart, as it is not typically seen in SLE:

Choice A rationale Erosive arthritis is not typically associated with Systemic Lupus Erythematosus (SLE). While many SLE patients experience joint pain and swelling known as lupus arthritis, it is characteristically non-erosive and non-deforming. This distinguishes it from rheumatoid arthritis, where the inflammatory process actively destroys bone and cartilage. In SLE, the joint involvement is usually transient and does not show the classic "punched-out" erosions on radiographic imaging, making this finding an unlikely or invalid sign for a typical SLE diagnosis. Choice B rationale Pericarditis is a well-recognized manifestation of Systemic Lupus Erythematosus and is the most common cardiac complication of the disease. It involves inflammation of the pericardium, the sac surrounding the heart, which can cause chest pain and a pericardial friction rub. Since SLE is a multisystem inflammatory disease that frequently targets serous membranes, the presence of pericarditis is highly consistent with the pathology of SLE and would be a valid sign found in a patient's medical record. Choice C rationale Photosensitivity is a classic and highly valid sign of Systemic Lupus Erythematosus. Approximately 60 to 90 percent of patients with SLE experience an abnormal reaction to ultraviolet (UV) light, which can trigger both skin rashes and systemic disease flares. UV exposure causes skin cell damage and the release of nuclear antigens that react with circulating antibodies, worsening the autoimmune response. Therefore, a history of skin reactions to sunlight is a key diagnostic criterion for the condition. Choice D rationale A red, macular facial rash, commonly known as the malar or "butterfly" rash, is the most iconic physical sign of Systemic Lupus Erythematosus. This rash typically spreads across the bridge of the nose and the cheeks while sparing the nasolabial folds. It is a valid clinical finding that appears in a large percentage of patients, particularly during periods of disease activity. Its presence is one of the primary physical markers used by clinicians to identify and monitor SLE.